BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu XY, Zhang N, Zhang SX, Xu P. Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1. Eur J Neurosci 2021;54:7749-69. [PMID: 34676939 DOI: 10.1111/ejn.15502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Du H, Meng X, Yao Y, Xu J. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1033479] [Reference Citation Analysis]
2 Yadav P, Lee YH, Panday H, Kant S, Bajwa N, Parashar R, Jha SK, Jha NK, Nand P, Lee SS, Jha AK. Implications of Microorganisms in Alzheimer's Disease. Curr Issues Mol Biol 2022;44:4584-615. [PMID: 36286029 DOI: 10.3390/cimb44100314] [Reference Citation Analysis]
3 Zhu S, Bai Q, Li L, Xu T. Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.05.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]